Searchable abstracts of presentations at key conferences in endocrinology

ea0061cd2.1 | Case Discussions: complex clinical cases 2.0 | OU2019

Factors related to Non-Alcoholic Fatty Liver Disease (NAFLD) measures in obese subjects with early Type 2 Diabetes mellitus

Zaghloul Hadeel , Chagoury Odette , McGowan Barbara , Taheri Shahrad , DIADEM-1 Study Team Shahrad

Introduction: T2DM (type 2 diabetes mellitus) appears to worsen the course of NAFLD (Non-Alcoholic Fatty Liver Disease) and NAFLD can make diabetes management more challenging. Long-term, NAFLD can lead to liver fibrosis, steatohepatitis, cirrhosis, and end-stage liver disease. This study aimed to examine factors associated with NAFLD measures in early T2DM.Methods: Subjects (n=144) with early T2DM (<=3 years) and obesity (BMI>=27 kg/m<s...

ea0034p117 | Clinical practice/governance and case reports | SFEBES2014

Polycythaemia is a common side-effect of testosterone therapy, regardless of treatment mode, and careful monitoring of haematological indices is required

Bhatti Rahila , Grimmett Belinda , McCarthy Maeve , Agusttson Tomas , McGowan Barbara , Powrie Jake , Carroll Paul

Background: Testosterone replacement is the mainstay of treatment for male hypogonadism. The most commonly reported adverse event in testosterone trials is polycythaemia. This study assessed the prevalence of polycythaemia in males receiving testosterone replacement and compared prevalence rates between different treatment preparations.Methods: 216 men were included in this retrospective observational study conducted from January 2009 to December 2012. 1...

ea0033p89 | (1) | BSPED2013

Low remission rates and high failure rate for medical treatment of thyrotoxicosis in childhood and adolescence: strategic implications for stopping antithyroid drugs

Al-Towati Mabrouka , McGowan Sheena , Hunter Ian , Williamson Scott , Ahmed Faisal , Donaldson Malcolm

Background: Paediatric thyrotoxicosis due Graves’ disease (GD)and Hashimoto’s thyroiditis (HT) disease is both more rare yet more severe than in adulthood. Antithyroid drug treatment (ATD) is with carbimazole or PTU either alone (dose titration (DT)) or with L-thyroxine (L-T4) – block and replace (BR).Methods: We have examined outcome of medical treatment in a cohort of patients treated from 1989 to...

ea0032p178 | Cardiovascular Endocrinology &amp; Lipid Metabolism | ECE2013

Intestinal cholesterol-transport gene expression is associated with abnormalities in post-prandial endothelial function and carotid intima-media thickness independent of insulin resistance

Widdowson W Matthew , McGowan Anne , Phelan James , Boran Gerard , Reynolds John , Gibney James

Introduction: Intestinal cholesterol absorption is known to be important in post-prandial lipid levels, and implicated in the development of vascular disease. This study evaluated the effect of intestinal gene expression on markers of early vascular disease in a cohort of diabetic and non-diabetic subjects.Methods: Subjects were identified from routine upper GI lists and enrolled as per local ethics approval. Intestinal gene expression was measured on du...

ea0032p990 | Thyroid (non-cancer) | ECE2013

Postprandial studies uncover differing effects on HDL particles of overt and subclinical hypothyroidism

McGowan Anne , M Widdowson William , O'Regan Anna , S Young Ian , Boran Gerard , McEneny Jane , Gibney James

Overt hypothyroidism (OH) and more controversially subclinical hypothyroidism (SCH) are associated with abnormal lipid metabolism and endothelial dysfunction under fasting conditions. Little data exists regarding the metabolic and vascular effects of OH or SCH under postprandial conditions.We aimed to characterize postprandial metabolism with emphasis on intestinally derived lipoproteins, HDL-cholesterol (HDL-C) and endothelial function in patients with ...

ea0031p209 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2013

The endocrine and metabolic characteristics of a large Bardet–Biedl syndrome clinic population

Mujahid Safa , Huda Mohammed , Forsythe Elizabeth , Hazlehurst Jonathan , Tomlinson Jeremy , Beales Philip , Carroll Paul , McGowan Barbara

Background: Bardet Biedl syndrome (BBS) is a rare autosomal recessive disorder caused by ciliary dysfunction. It is characterised by rod cone dystrophy, polydactyly, renal dysfunction, cognitive impairment. Endocrine consequences are thought to include hypogonadism, obesity and polyuria. However little is known about the endocrine and metabolic abnormalities in adult patients.Methods: One hundred and fifty-four patients with BBS were identified through t...

ea0021p142 | Diabetes and metabolism | SFEBES2009

Healthcare professionals frequently fail to recognise severe obesity

Ahern Tomas , McGowan Anne , Davis Maeve , Billfalk-Kelly Astrid , O'Shea Donal

Severe obesity continues to dramatically increase in prevalence and is associated with significant mortality and morbidity. The American Society of Metabolic and Bariatric Surgery recommends that bariatric surgery only be performed on those with severe obesity. Gastric bypass surgery decreases mortality by 40% at 7.5 years.Using photographs of volunteers from a hospital based weight management clinic, we performed a survey of endocrinologists, general pr...

ea0021p404 | Thyroid | SFEBES2009

Sunitinib induced hypothyroidism: a retrospective analysis

Muralidhara Koteshwara , Joseph Debra , Guzder Rustom , Rudman Sarah , McGowan Barbara , Chowdhury Simon , Carroll Paul , Powrie Jake

Sunitinib, a tyrosine kinase inhibitor, inhibits VEGF-mediated tumour angiogenesis. Following NICE approval, it is increasingly used in the treatment of metastatic renal cell carcinoma.Hypothyroidism in sunitinib-treated individuals was first described in 2005. The aetiology remains uncertain and possibly reflects a destructive thyroiditis. Incidence rates of hypothyroidism from case series vary between 36 and 85%. We report a retrospective analysis of t...

ea0019p271 | Pituitary | SFEBES2009

The challenges in managing prolactinomas in patients with psychiatric illness treated with antipsychotic medication

Mehta SR , McGowan BMC , Ghaffar A , Shaikh H , Martin NM , Hatfield ECI , Meeran K

Antipsychotic induced hyperprolactinaemia, mediated by blockade of dopamine D2 receptors, is much more common than prolactinoma in patients receiving antipsychotic medication. We present two cases of the latter.Case 1: A 47-year-old gentleman with depression treated with amitriptyline, fluoxetine and risperidone presented with headaches and a left sided visual field defect. Pituitary MRI showed a 2 cm macroadenoma abutting the optic chiasm. Prolactin was...

ea0018p4 | (1) | MES2008

Management of a phaeochromocytoma in pregnancy

McGowan Barbara , Williamson Catherine , Meeran Karim , Banerjee Anita , Min Lee , Fleming Bill , Bassett Duncan , Tan Tricia

A 30-year-old lady was transferred to our hospital at 37 weeks of pregnancy. Hypertension was noted at 24 weeks of gestation and managed with methyldopa and labetalol. Despite treatment, BP was labile with a systolic of 90–220 and diastolic of 50–129 mmHg. She reported occasional palpitations but not chest pain or shortness of breath. The patient had a history of migrainous headaches but not hypertension prior to pregnancy. Her brother had previously had an operation...